Teva announces availability of generic equivalent of EpiPen JrŽ (epinephrine injection
Teva announced availability of the FDA-approved generic version of EpiPen JrŽ1 (epinephrine injection, USP) Auto-Injector, 0.15 mg, in the U.S. The product is available in most retail pharmacies, and the Wholesale Acquisition Cost is $3002 for a 2-pack. August 20, 2019